Radient Pharmaceuticals (RPC) Tops Q4 EPS by 26c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Radient Pharmaceuticals (NYSE: RPC) | Delayed: 9.68 +0.28 (2.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.40 | 52 Week High | $1.69 | |||
| Open | $8.54 | 52 Week Low | $0.14 | |||
| Day High | $10.05 | P/E | N/A | |||
| Day Low | $8.54 | EPS | $-3.02 | |||
| Volume | 755,569 | |||||
